Effects of the Perindopril/Amlodipine Fixed-Dose Combination Therapy on the Left Ventricular Myocardial Deformation Properties and Arterial Stiffness Parameters in Patients with Arterial Hypertension

ORIGINAL ARTICLE
S. I. Bekmetova, G. Zh. Abdullaeva, G. A. Khamidullaeva, Sh. S. Fayzullaeva, Kh. F. Yusupova, F. A. Zakirova

 
For citation: Bekmetova SI, Abdullaeva GZh, Khamidullaeva GA, Fayzullaeva ShS, Yusupova KhF, Zakirova FA. Effects of the Perindopril/Amlodipine Fixed-Dose Combination Therapy on the Left Ventricular Myocardial Deformation Properties and Arterial Stiffness Parameters in Patients with Arterial Hypertension. International Journal of Biomedicine. 2024;14(4):551-557. doi:10.21103/Article14(4)_OA2
 
Originally published December 5, 2024
 

Abstract: 

Background: Arterial hypertension (AH) is one of the main factors determining the high risk of cardiovascular complications and mortality. Early diagnosis of AH is a key point in its effective control and prevention of severe consequences. In recent years, the deformation properties of the left ventricle have been actively studied in the context of early diagnosis of AH and evaluation of the effectiveness of antihypertensive therapy. Our study aimed to assess effectiveness of the six-month perindopril/amlodipine fixed-dose combination (FDC) therapy on the deformation properties of the left ventricular (LV) myocardium and the elastic properties of arteries in AH patients.
Methods and Results: This study included 55 patients (20 men and 35 women) with AH Grades 1-2 (ESC/ESH, 2018). The mean age of patients was 52.2±10.94 years; the average duration of AH was 7.51±6.77 years.
All patients underwent general clinical examination, biochemical blood tests, standard transthoracic two-dimensional echocardiography with ECG synchronization, 2D-speckle tracking echocardiography (STE) with the assessment of global longitudinal strain [GLS] and strain rate (SR). Arterial stiffness was determined using applanation tonometry. All patients received a perindopril/amlodipine FDC. The drug dose, considering the maximum doses, was titrated at 2-week intervals to achieve a target blood pressure. The mean doses of perindopril and amlodipine were 4.4±1.2 mg/day and 7.86±2.5 mg/day, respectively.  The final treatment results were determined after 6 months of antihypertensive therapy.
Depending on the types of LV echo-geometry, AH patients were divided into three groups: Group 1 included 25 AH patients with normal LV geometry, Group 2 included 25 AH patients with LV concentric remodeling, and Group 3 included 5 AH patients with concentric LVH. The LV GLS values ​​were -18.0±2.95%, -14.16±2.99%, and -12.4±1.87% in Groups 1, 2, and 3, respectively (P=0.0000). Intergroup analysis showed normal GLS value ​​in Group 1, compared with Groups 2 and 3 (P1-2=0.0001 and P1-3=0.0007, respectively). Correlation analysis between the studied parameters revealed direct correlations of the LV mass index (LVMI) with GLS (rs=0.70, P=0.000), SR (rs=0.70, P=0.000), and pulse wave velocity (PWV) (rs=0.4, P=0.000). In addition, direct correlations were observed between the PWV and GLS (rs=0.50, P=0.000) and SR (rs=0.50, P=0.000). A direct correlation was also noted between LV ejection fraction (LVEF) and SR (rs=0.70, P=0.000).
Before the start of therapy, the average systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 163.05±13.7 mmHg and 96.4±10.7 mmHg, respectively. Analysis of the six-month perindopril/amlodipine FDC therapy in AH patients showed high antihypertensive efficacy. The target levels of SBP and DBP were achieved in 98.2% and 96.4% of patients, respectively.  There was a significant positive dynamic in reducing LVMI (from 96.40±25.79 g/m2 to 82.3±24.5 g/m2, P=0.000).  The LVEF also improved from 63.08±2.59% to 64.57±1.82% (P=0.000). The six-month perindopril/amlodipine FDC therapy positively influenced the LV myocardium deformation properties: GLS increased significantly from -15.0±3.2% to 19.09±2.8%, reaching the normative values (P<0.001); SR also increased significantly from 0.84±0.23s⁻¹ to -1.13±0.23s⁻¹ (P<0.001). The indicated therapy was effective for central hemodynamics and arterial stiffness.
Conclusion: In AH patients with LV concentric hypertrophy, significant disturbances in the LV deformation properties are formed. The six-month perindopril/amlodipine FDC therapy provides good antihypertensive, cardioprotective, and vasoprotective efficacy, which is expressed in reliable regression of left ventricular hypertrophy, positive effect on the LV deformation properties, and increased elasticity of the arteries.

Keywords: 
arterial hypertension • left ventricular echo-geometry • global longitudinal strain • strain rate • arterial stiffness • pulse wave velocity • fixed-dose combination therapy
References: 
  1. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18. PMID: 35529086; PMCID: PMC9073222.
  2. Poznyak AV, Sadykhov NK, Kartuesov AG, Borisov EE, Melnichenko AA, Grechko AV, Orekhov AN. Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. Front Cardiovasc Med. 2022 Aug 22;9:959285. doi: 10.3389/fcvm.2022.959285. PMID: 36072873; PMCID: PMC9441708.
  3. Fuchs FD, Whelton PK. High Blood Pressure and Cardiovascular Disease. Hypertension. 2020 Feb;75(2):285-292. doi: 10.1161/HYPERTENSIONAHA.119.14240. Epub 2019 Dec 23. PMID: 31865786; PMCID: PMC10243231.
  4. Guidelines (JSH 2014). Chapter 1. Epidemiology of hypertension. Hypertens Res. 2014;37:260–265. doi; 10.1038/hr.2014.4
  5. Burnier M, Damianaki A. Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease. Circ Res. 2023 Apr 14;132(8):1050-1063. doi: 10.1161/CIRCRESAHA.122.321762. Epub 2023 Apr 13. PMID: 37053276.
  6. Kourtidou C, Tziomalos K. Epidemiology and Risk Factors for Stroke in Chronic Kidney Disease: A Narrative Review. Biomedicines. 2023 Aug 27;11(9):2398. doi: 10.3390/biomedicines11092398. PMID: 37760839; PMCID: PMC10525494.
  7. World Health Organization. Number of people living with hypertension has doubled to 1.28 billion since 1990. Available from: https://www.who.int/news/item/25-08-2021-more-than-700-million-people-wi...
  8. Huang QF, Yang WY, Asayama K, Zhang ZY, Thijs L, Li Y, O'Brien E, Staessen JA. Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension. Hypertension. 2021 Feb;77(2):254-264. doi: 10.1161/HYPERTENSIONAHA.120.14591. Epub 2021 Jan 4. PMID: 33390042; PMCID: PMC7803442.
  9. Pacurari M, Kafoury R, Tchounwou PB, Ndebele K. The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam. 2014;2014:689360. doi: 10.1155/2014/689360. Epub 2014 Apr 6. PMID: 24804145; PMCID: PMC3997861.
  10. González A, Ravassa S, López B, Moreno MU, Beaumont J, San José G, Querejeta R, Bayés-Genís A, Díez J. Myocardial Remodeling in Hypertension. Hypertension. 2018 Sep;72(3):549-558. doi: 10.1161/HYPERTENSIONAHA.118.11125. PMID: 30354762.
  11. Ryabikov AN, Guseva VP, Voronina EV, Palekhina YuYu, Shakhmatov SG, Verevkin EG, Holmes MV, Bobak M, Malyutina SK. [An association between echocardiographic left ventricle longitudinal strain and hypertension in general population depending on blood pressure control]. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2019;25(6):653-664. (In Russ.) doi: 10.18705/1607-419X-2019-25-6-653-664
  12. Duncan AE, Alfirevic A, Sessler DI, Popovic ZB, Thomas JD. Perioperative assessment of myocardial deformation. Anesth Analg. 2014 Mar;118(3):525-44. doi: 10.1213/ANE.0000000000000088. PMID: 24557101; PMCID: PMC4066464.
  13. Weidemann F, Jamal F, Sutherland GR, Claus P, Kowalski M, Hatle L, De Scheerder I, Bijnens B, Rademakers FE. Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H792-9. doi: 10.1152/ajpheart.00025.2002. PMID: 12124229.
  14. Truong VT, Phan HT, Pham KNP, Duong HNH, Ngo TNM, Palmer C, Nguyen TTH, Truong BH, Vo MA, Tretter JT, Nagueh SF, Chung ES, Mazur W. Normal Ranges of Left Ventricular Strain by Three-Dimensional Speckle-Tracking Echocardiography in Adults: A Systematic Review and Meta-Analysis. J Am Soc Echocardiogr. 2019 Dec;32(12):1586-1597.e5. doi: 10.1016/j.echo.2019.07.012. Epub 2019 Oct 11. PMID: 31611158.
  15. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003. PMID: 25559473.
  16.  Galderisi M, Cosyns B, Edvardsen T, Cardim N, Delgado V, Di Salvo G, Donal E, Sade LE, Ernande L, Garbi M, Grapsa J, Hagendorff A, Kamp O, Magne J, Santoro C, Stefanidis A, Lancellotti P, Popescu B, Habib G; 2016–2018 EACVI Scientific Documents Committee; 2016–2018 EACVI Scientific Documents Committee. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1301-1310. doi: 10.1093/ehjci/jex244. PMID: 29045589.
  17. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1. Erratum in: J Am Coll Cardiol. 2023 Apr 18;81(15):1551. doi: 10.1016/j.jacc.2023.03.002. PMID: 35379503.
  18. D'Elia N, Caselli S, Kosmala W, Lancellotti P, Morris D, Muraru D, Takeuchi M, van den Bosch A, van Grootel RWJ, Villarraga H, Marwick TH. Normal Global Longitudinal Strain: An Individual Patient Meta-Analysis. JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):167-169. doi: 10.1016/j.jcmg.2019.07.020. Epub 2019 Aug 31. PMID: 31481298.
  19. Levy PT, Sanchez Mejia AA, Machefsky A, Fowler S, Holland MR, Singh GK. Normal ranges of right ventricular systolic and diastolic strain measures in children: a systematic review and meta-analysis. J Am Soc Echocardiogr. 2014 May;27(5):549-60, e3. doi: 10.1016/j.echo.2014.01.015. Epub 2014 Feb 26. PMID: 24582163; PMCID: PMC4031687.
  20. Frolova EV. [Hypertension]. Russian Family Doctor. 2016;20(2):6-18. [In Russian].
  21. Buziashvili IuI, Koksheneva IV, Asymbekova EU, Turakhonov TK. [Left ventricular and papillary muscles deformation in patients with coronary artery disease and ischemic mitral regurgitation]. Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(2):100‑109. (In Russian)
  22. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019 Feb 1;40(5):475. PMID: 30165516.
  23. Boytsov SA. [Study of the pathogenesis of hypertension continues]. Ter Arkh. 2006;(9):5-12. [In Russian].
  24. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006 Nov;27(21):2588-605. doi: 10.1093/eurheartj/ehl254. Epub 2006 Sep 25. PMID: 17000623.
  25. Boutouyrie P, Laurent S, Briet M. Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs. Fundam Clin Pharmacol. 2008 Jun;22(3):241-6. doi: 10.1111/j.1472-8206.2008.00584.x. PMID: 18485143.
  26. Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, Gottdiener J, Haluska B, Ofili E, Segers P, Senior R, Tapp RJ, Zamorano JL. Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015 Jul;28(7):727-54. doi: 10.1016/j.echo.2015.05.002. PMID: 26140936.
  27. Wu JC, Gillam LD, Solomon SD. Echocardiography, in: Libby RP, Bonow RO, Mann DL, Tomaselli G, Bhatt DL, Solomon SD, et al. (Eds.), Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine, twelfth ed. Elsevier, Philadelphia, 2022:196–267.
  28. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011 Jan;4(1):98-108. doi: 10.1016/j.jcmg.2010.10.008. PMID: 21232712.
  29. Tanaka H. Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. J Echocardiogr. 2021 Jun;19(2):71-79. doi: 10.1007/s12574-020-00508-3. Epub 2021 Jan 18. PMID: 33460030; PMCID: PMC8154763.
  30. Brzozowska-Czarnek A, Bryll A. Ocena przerostu mieśnia lewej komory serca u pacjentów z pierwotnym nadciśnieniem tetniczym przy pomocy badania Kardio MR [The assessment of left ventricular hypertrophy in patients with the primary hypertension with the use of Cardiac Magnetic Resonance]. Przegl Lek. 2013;70(5):255-61. Polish. PMID: 23944093.
  31. Vdovenko DV, Libis RA. [The myocardial deformation and diastolic function of the left ventricle in patients with heart failure with preserved left ventricular ejection fraction]. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2018;24(1):74-80. [In Russian]. doi: 10.18705/1607-419X-2018-24-1-74-80
  32. Hazukova R, Rezacova M, Pleskot M, Zadak Z, Cermakova E, Taborsky M. DNA damage and arterial hypertension. A systematic review and meta-analysis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Mar;168(1):15-24. doi: 10.5507/bp.2023.044. Epub 2023 Oct 30. PMID: 37916467.
  33. Dolan E, Stanton AV, Thom S, Caulfield M, Atkins N, McInnes G, Collier D, Dicker P, O'Brien E; ASCOT Investigators. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens. 2009 Apr;27(4):876-85. doi: 10.1097/HJH.0b013e328322cd62. PMID: 19516185.
  34. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens. 2001 Jun;19(6):1139-47. doi: 10.1097/00004872-200106000-00020. PMID: 11403364.
  35. Poulter NR, Wedel H, Dahlöf B, Sever PS, Beevers DG, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, Pocock S; ASCOT Investigators. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005 Sep 10-16;366(9489):907-13. doi: 10.1016/S0140-6736(05)67186-3. PMID: 16154017.
  36. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182. PMID: 19052124.
  37. Mukhin NA, Moiseev VS, Kobalava ZhD, et al. [Cardiorenal interactions: clinical significance and role in the pathogenesis of cardiovascular and kidney diseases]. Ter Arkh. 2004;(6):39-46. [In Russian].
  38. Burnier M, Brown RE, Ong SH, Keskinaslan A, Khan ZM. Issues in blood pressure control and the potential role of single-pill combination therapies. Int J Clin Pract. 2009 May;63(5):790-8. doi: 10.1111/j.1742-1241.2009.01999.x. Epub 2009 Feb 11. PMID: 19220523.
  39. Messerli FH. Calcium antagonists in hypertension: from hemodynamics to outcomes. Am J Hypertens. 2002 Jul;15(7 Pt 2):94S-97S. doi: 10.1016/s0895-7061(02)02950-3. PMID: 12121012.
  40. Quan A, Chavanu K, Merkel J. A review of the efficacy of fixed-dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studies. Am J Cardiovasc Drugs. 2006;6(2):103-13. doi: 10.2165/00129784-200606020-00004. PMID: 16555863.
  41. Robles NR, Ocon J, Gomez CF, Manjon M, Pastor L, Herrera J, Villatoro J, Calls J, Torrijos J, Rodríguez VI, Rodriguez MM, Mendez ML, Morey A, Martinez FI, Marco J, Liebana A, Rincon B, Tornero F. Lercanidipine in patients with chronic renal failure: the ZAFRA study. Ren Fail. 2005;27(1):73-80. PMID: 15717638.
  42. Stergiou GS, Makris T, Papavasiliou M, Efstathiou S, Manolis A. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy. J Hypertens. 2005 Apr;23(4):883-9. doi: 10.1097/01.hjh.0000163159.22116.ab. PMID: 15775795.
  43. Mashkurova ZT, Abdullaeva GZh, Khamidullaeva GA, Sherbadalova NKh, Khatamova MN, Safarov ZhB, Atoeva MI. Clinical Efficacy of Combined Use of Azilsartan with Indapamide and Azilsartan with Nitrendipine in Patients with Arterial Hypertension. International Journal of Biomedicine. 2022;12(3):367-374. doi:10.21103/Article12(3)_OA3.

Download Article
Received October 22, 2024.
Accepted November 26, 2024.
©2024 International Medical Research and Development Corporation.